ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, P
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hill, P
Topic Collections
Right arrowRelated Articles
Archives of Disease in Childhood 2005;90:i1
© 2005 BMJ Publishing Group & Royal College of Paediatrics and Child Health

EDITORIAL
Attention deficit/hyperactivity disorder

Introduction

P Hill

Great Ormond Street Hospital for Children NHS Trust, Department of Psychological Medicine, Great Ormond Street Hospital for Children, Great Ormond Street, London WC1N 3JH, UK; prof@17wimpole.com

Professor Peter Hill, Honorary Consultant in Psychological Medicine at Great Ormond Street Children’s Hospital, introduces this supplement on attention deficit/hyperactivity disorder

The first 150 words of the full text of this article appear below.

Attention deficit/hyperactivity disorder (ADHD) is a pattern of pervasive behavioural and cognitive symptoms, characterised by excessive and impairing hyperactive, inattentive, and impulsive behaviour. It is one of the most frequent childhood behavioural disorders, with symptoms often persisting across adolescence into adulthood.

The Diagnostic and Statistical Manual of Diseases - Fourth Revision (DSM-IV)1 allows for the differentiation of ADHD into three subtypes: (1) predominantly inattentive, (2) hyperactive/impulsive, and (3) combined.2 The International Classification of Diseases—10th Revision, (ICD-10)3 is a much narrower diagnosis whereby only a subset of the DSM-IV ADHD group is identified, equivalent to a severe combined type.

Existing epidemiological data suggest that 1% of school age children in the UK are affected by the severe combined form and around 5% to some lesser degree, though still within the diagnostic boundary.4 This equates to around 69 000 6–16 year olds in England being severely affected and 345 . . . [Full text of this article]


Related Articles

Attention deficit/hyperactivity disorder and ethnicity
K N Dwivedi and R G Banhatti
Arch. Dis. Child. 2005 90: i10-i12. [Abstract] [Full Text] [PDF]

A new paradigm for developing drugs in children: atomoxetine as a model
S Prasad
Arch. Dis. Child. 2005 90: i13-i16. [Abstract] [Full Text] [PDF]

Off licence and off label prescribing in children: litigation fears for physicians
P Hill
Arch. Dis. Child. 2005 90: i17-i18. [Abstract] [Full Text] [PDF]

Managing attention deficit/hyperactivity disorder: unmet needs and future directions
C R Steer
Arch. Dis. Child. 2005 90: i19-i25. [Abstract] [Full Text] [PDF]

The effect of ADHD on the life of an individual, their family, and community from preschool to adult life
V A Harpin
Arch. Dis. Child. 2005 90: i2-i7. [Abstract] [Full Text] [PDF]

Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder
J Barton
Arch. Dis. Child. 2005 90: i26-i29. [Abstract] [Full Text] [PDF]

The parent’s perspective
M Colley
Arch. Dis. Child. 2005 90: i8-i9. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health